SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001104659-24-023789
Filing Date
2024-02-14
Accepted
2024-02-14 16:26:22
Documents
2
Group Members
JEREMY C. GREENREDMILE BIOPHARMA INVESTMENTS I, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm245846d23_sc13ga.htm SC 13G/A 86395
2 EXHIBIT 99.1 tm245846d23_ex99-1.htm EX-99.1 6947
  Complete submission text file 0001104659-24-023789.txt   95341
Mailing Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011
Business Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011 (877) 237-5020
Neurogene Inc. (Subject) CIK: 0001404644 (see all company filings)

IRS No.: 980542593 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88050 | Film No.: 24638933
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129
Business Address ONE LETTERMAN DRIVE BUILDING D, SUITE D3-300 SAN FRANCISCO CA 94129 415-489-9980
Redmile Group, LLC (Filed by) CIK: 0001425738 (see all company filings)

IRS No.: 208592298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A